JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC (the 'Company') |
|
Legal Entity Identifier: 549300NFZYYFSCD52W53 |
|
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 29 February 2020 |
|
GlaxoSmithKline |
4.8% |
JPMorgan Smaller Companies Investment Trust |
4.5% |
AstraZeneca |
4.3% |
Royal Dutch Shell |
4.3% |
British American Tobacco |
3.5% |
HSBC |
2.7% |
Legal & General |
2.3% |
RELX |
2.3% |
Lloyds Banking |
2.1% |
Prudential |
2.1% |
Total |
32.7% |
Excludes Investments in Liquidity stocks |
|
Name of contact and telephone number for queries: |
|
Paul Ainger 0044 207 742 6524 |
|
Name of authorised company official responsible for making this notification: |
|
Faith Pengelly 0044 207 742 8627 - Company Secretary |
|
Date: 11 March 2020 |
|
|
|